Fortrea Holdings Inc. (FTRE)
NASDAQ
Closed
Oct 23, 2026
Day's Range
23.4252 wk Range
8.55Overview - FTRE - Fortrea Holdings Inc.
Key Statistics
Valuation
Enterprise Value
2.93B
P/E (Trailing)
522.33
P/E (Forward)
18.54
PEG Ratio
-5.40
Price / Sales (TTM)
0.74
Price / Book
3.79
EV / EBITDA
29.81
Profitability
Gross Margin
20.52%
Profit Margin
-3.18%
Operating Margin
2.57%
Return on Assets
0.58%
Return on Equity
-15.30%
Ownership
Shares Outstanding
95.10M
Float
93.98M
Short % of Shares Outstanding
15.52%
Held by Insiders
1.22%
Held by Institutions
108.27%
Price stats
Beta
1.90
50-Day Avg
18.91
200-Day Avg
15.28
Dividends
Payout Ratio
0.00%
Analyst Consensus
13 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - FTRE - Fortrea Holdings Inc.
Peers - FTRE - Fortrea Holdings Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- FTRENASDAQFortrea Holdings Inc.1.99BMarket Cap+54.52%52-week change522.33P/E (Trailing)-3.18%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - FTRE - Fortrea Holdings Inc.
About
Fortrea Holdings Inc. is a global contract research organization that provides clinical development solutions to pharmaceutical, biotechnology, and medical device companies. Fortrea Holdings Inc. supports clients across the full clinical trial lifecycle, including Phase I through Phase IV studies, clinical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
